Prostate Cancer Clinical Masterclass Series

This month we are joined by Dr Vivek Narayan who is assistant Professor of medicine at the Abramson Cancer Center, University of Pennsylvania, who discusses What Limits the Efficacy of CAR-T Cell Therapies for Advanced Prostate Cancer. We also hear from our co-chair, Dr Sumit Subudhi, from MD Anderson Cancer Center, Texas, who will present on The Path Forward for Immune Checkpoint Therapies. Dr Subudhi also co-chairs the session and leads the disucssion to close the episode.

This month we are joined by Dr Emmanuel Antonarakis, from The University of Minnesota, USA, who discusses the exciting topic of B7-H3 as a New Drug Target in Prostate Cancer. This month is co-chaired by Dr Gert Attard, from The University College London, who leads the question-led disucssion to close the episode.

This month we are joined by Dr Mary-Ellen Taplin, from Dana Farber Cancer Institute,  USA, who discusses Neo-adjuvant Therapies for Prostate Cancer. We will also hear from Prof Janet Brown, from The University of Sheffield, U.K., who will present on Bone Protection in Prostate Cancer. It is co-chaired by Dr Sumit Subudhi, from MD Anderson Cancer Center, who leads the group disucssion to close the episode.

This month we are joined by Prof Ros Eeles, from The Institute of Cancer Research, U.K., who discusses Germline Testing Families of Prostate Cancer Patients. We will also hear from Dr Joaquin Mateo, from Val d'Hebron, Barcelona, Spain, who will present on Targeting Homologous Recombination Repair Deficiency. It is co-chaired by Dr Gerhardt Attard, from University College London, U.K., who leads the group disucssion to close the episode.

This month we are joined by Prof Michael Hofman, from PeterMac in Melbourne, Austrialia, who discusses Theranostics in Prostate Cancer. We will also hear from Dr Veeru Kasivisvanathan, from University College London, U.K., who will present on Best Use of MRI for Prostate Cancer Diagnosis. It is co-chaired by Dr Gerhardt Attard, from University College London, U.K., who leads the group disucssion to close the episode.

This month we are joined by Dr Daniel Spratt, from University Hospitals Seidman Cancer Center/ Case Western Reserve University, who discusses Molecular Classifiers for Treatment Rationalisation of Localised Disease. We will also hear from Prof Bertrand Tombal, from Université catholique de Louvain, Louvain-la-Neuve, who will present on LHRH Antagonists vs Agonists. It is co-chaired by Dr Sumit Subudhi, from MD Anderson Cancer Center, who leads the group disucssion to close the episode.